Rare Enterprises
Healthcare
Multiples PE mulls an exit move from healthcare portfolio firm
Private equity firm Multiples Alternate Asset Management is exploring the possibility of monetizing its investment in a four-year-old portfolio company ......
Healthcare
Bottomline: PE-backed Zenex gets a boost with Ayurvet M&A, explores new growth areas
Zenex Animal Health India Pvt Ltd, formed after private equity firm Multiples PE and a consortium of investors acquired and ......
Consumer
Local edtech player gets $150-mn tag as Rare Enterprises' CEO joins cap table
A Mumbai-based edtech company, which recently onboarded Rare Enterprise chief Utpal Sheth as an investor, is set to ride the ......
Healthcare
Jhunjhunwala family-backed IKS Health may trim IPO size
IKS Health, a Mumbai-based healthtech platform majority owned by the late stock market investor Rakesh Jhunjhunwala’s Rare Enterprises, is contemplating ......
Healthcare
Rakesh Jhunjhunwala firm-backed Concord Biotech files for IPO
Late billionaire investor Rakesh Jhunjhunwala's firm Rare Enterprises-backed Concord Biotech has filed its draft red herring prospectus (DRHP) with capital ......
Healthcare
Quadria Capital to sell stake in API maker Concord Biotech
Healthcare-focused private equity fund Quadria Capital will sell its entire 20% stake in active pharmaceutical ingredients maker Concord Biotech in ......
Healthcare
Multiples-led consortium to buy an animal health biz of Zydus Cadila
A consortium led by private equity firm Multiples Alternate Asset Management has agreed to acquire an animal health business from ......
General
Grapevine: Munjal, DSP Group founder eye Yes Bank stake; Bharti bids for R-Com assets
Sunil Munjal, chairman of Hero Corporate Services Ltd, and Hemendra Kothari, veteran investment banker and founder of DSP Group, have ......
General
Carlyle eyes stake in SBI Life; Banks, Rakesh Jhunjhunwala bid for IL&FS Securities
US-based private equity giant The Carlyle Group is ahead in the race to pick up a stake in SBI Life ......
Healthcare
Company watch: Concord Biotech eyes new opportunities after Quadria's backing
Biotechnologist Sudhir Vaid quit drugmaker Ranbaxy Laboratories Ltd exactly 20 years ago to start his entrepreneurial journey. The Ahmedabad-based biotechnology ......
Most Popular
Google News
Follow VCCircle on Google News for the latest updates on Business and Startup News